Skip to content

A Randomized, Double-Blind, Placebo-Controlled Clinical Trial Evaluating the Efficacy of Transfer Factor TFI Treatment by Assessing the Number of New Infections in Subjects with Recurrent Respiratory or Urinary Tract Infections or Recurrent Herpetic Infections Recorded over a Period of 6 Months from Randomization

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-516879-32-00
Enrollment
100
Registered
2025-01-08
Start date
2025-06-13
Completion date
Unknown
Last updated
2025-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

• Recurrent respiratory infections • Recurrent urinary tract infections • Recurrent herpetic infections

Interventions

None listed

Sponsors

Aumed a.s.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Czechia

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026